Immunovant, Inc. IMVT · Insights

website

315

Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to advanci...

Price35.15

Market Cap7.19 B

Float84.83 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

Key Dates & Timelines

Form Type

Date

Description

Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro

Financial Transactions

Form Type

Date

Description

Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro